Minnetronix Inc (Minnetronix) is a medical device company that offers medical system integrators. The company designs electronic and electromechanical systems. It offers products such as intraperitoneal heating and fluids control, brain stimulation system, 3-D imaging for ear canal measurement, breast tissue ablation and biopsy sample removal, external pulse generator for incontinence therapy, wound management pump, cardiopulmonary bypass system, extracorporeal blood pump, laser ablation system, ultrasound mist wound management and point of care blood analyzers and others. The company provides services design and engineering, quality assurance, regulatory affairs and supply chain management, among others. Minnetronix is headquartered in Saint Paul, Minnesota, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Minnetronix Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Minnetronix Inc Company Overview
Minnetronix Inc Company Snapshot
Minnetronix Inc Pipeline Products and Ongoing Clinical Trials Overview
Minnetronix Inc – Pipeline Analysis Overview
Minnetronix Inc - Key Facts
Minnetronix Inc - Major Products and Services
Minnetronix Inc Pipeline Products by Development Stage
Minnetronix Inc Pipeline Products Overview
Neurapheresis System - Cryptococcal Meningitis
Neurapheresis System - Cryptococcal Meningitis Product Overview
Neurapheresis System - Leptomeningeal Metastases
Neurapheresis System - Leptomeningeal Metastases Product Overview
Neurapheresis System - Subarachnoid Hemorrhage
Neurapheresis System - Subarachnoid Hemorrhage Product Overview
Minnetronix Inc - Key Competitors
Minnetronix Inc - Key Employees
Minnetronix Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Minnetronix Inc, Recent Developments
Oct 20, 2020: Minnetronix Medical awarded National Institutes of Health grant for proprietary Neurapheresis product that removes blood from spinal fluid
Nov 04, 2019: Minnetronix Medical names Jeremy Maniak President and CEO
Oct 08, 2018: Minnetronix Neuro launches global neurapheresis consortium
Oct 01, 2018: Minnetronix Neuro successfully completes first clinical study in hemorrhagic stroke
Sep 10, 2018: Minnetronix announces rebrand to Minnetronix Medical
May 01, 2018: Minnetronix Names Elissa Lindsoe As Chief Financial Officer
Sep 01, 2017: Minnetronix Maintains Perfect Record with Seventh FDA Inspection
Jul 10, 2017: Facility Expansion and Leadership Appointment Signal Growth for Minnetronix
Aug 29, 2016: Minnetronix Names Anthony Millar Vice President of Operations
Nov 17, 2015: Minnetronix Names Will Sutton Vice President of Engineering and Technology